BioCentury | Nov 1, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: October 2018

...inhibiting ACMSD could help prevent non-alcoholic fatty liver disease (NAFLD) and acute kidney injury (AKI) TES Pharma s.r.l....
BioCentury | Oct 31, 2018
Distillery Therapeutics

Hepatic; renal

...steps by TES Pharma s.r.l. include clinical testing of TES-1025 and TES-991 in NAFLD and AKI patients. TES Pharma...
...admin.auwerx@epfl.ch CONTACT: Roberto Pellicciari, TES Pharma s.r.l., Corciano, Italy email: rpellicciari@tespharma.com Sandi Wong TES-1025 TES-991 Swiss Federal Institute of Technology Lausanne (EPFL) TES Pharma s.r.l. Aminocarboxymuconate...
BioCentury | Oct 25, 2018
Preclinical News

Inhibiting metabolic enzyme to prevent NAFLD, acute kidney injury

...loss of kidney function and decreased kidney damage in mice with induced acute kidney injury. TES Pharma...
...markets the drug to treat primary biliary cholangitis (PBC). Sandi Wong Swiss Federal Institute of Technology Lausanne (EPFL) TES Pharma s.r.l. Nicotinamide...
BioCentury | Aug 17, 2015
Company News

Ecole Polytechnique Federale de Lausanne, TES Pharma deal

...The companies could not provide additional details. Ecole Polytechnique Federale de Lausanne , Lausanne, Switzerland TES Pharma s.r.l....
Items per page:
1 - 4 of 4
BioCentury | Nov 1, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: October 2018

...inhibiting ACMSD could help prevent non-alcoholic fatty liver disease (NAFLD) and acute kidney injury (AKI) TES Pharma s.r.l....
BioCentury | Oct 31, 2018
Distillery Therapeutics

Hepatic; renal

...steps by TES Pharma s.r.l. include clinical testing of TES-1025 and TES-991 in NAFLD and AKI patients. TES Pharma...
...admin.auwerx@epfl.ch CONTACT: Roberto Pellicciari, TES Pharma s.r.l., Corciano, Italy email: rpellicciari@tespharma.com Sandi Wong TES-1025 TES-991 Swiss Federal Institute of Technology Lausanne (EPFL) TES Pharma s.r.l. Aminocarboxymuconate...
BioCentury | Oct 25, 2018
Preclinical News

Inhibiting metabolic enzyme to prevent NAFLD, acute kidney injury

...loss of kidney function and decreased kidney damage in mice with induced acute kidney injury. TES Pharma...
...markets the drug to treat primary biliary cholangitis (PBC). Sandi Wong Swiss Federal Institute of Technology Lausanne (EPFL) TES Pharma s.r.l. Nicotinamide...
BioCentury | Aug 17, 2015
Company News

Ecole Polytechnique Federale de Lausanne, TES Pharma deal

...The companies could not provide additional details. Ecole Polytechnique Federale de Lausanne , Lausanne, Switzerland TES Pharma s.r.l....
Items per page:
1 - 4 of 4